Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 December 2022 | Story Jóhann Thormählen | Photo Asem Engage/Hannes Naude
Sello Diphoko
Sello Diphoko was the Man of the Match in his last Varsity Football game for the University of the Free State.

Come to Kovsies and go places!’ is a motto used at Kovsie Soccer, and Sello Diphoko’s journey exemplifies this. The UFS striker’s humble beginnings and rise to the United States of America is one that inspires.

Two years ago, he didn’t even play club soccer, but he was scouted by the UFS and given an opportunity that changed his life. Diphoko recently received a scholarship at the University of the Incarnate Word in San Antonio, Texas.

Playing street football

It all started in February 2020 when he was invited to UFS soccer trials by a friend, Lwanda Ciko, who is also from Soutpan outside Bloemfontein.

“Before I came here, I was playing street football,” says Diphoko. “I have never played in a professional or semi-professional league; I came straight from the streets.” And it took Tebogo Motsamai, UFS head coach, only 25 minutes to identify his talent.

According to Godfrey Tenoff, Diphoko was attending Motheo College and gained access to the UFS through the University Preparation Programme.

“We are totally proud of Sello,” says the Head of Soccer at KovsieSport. “He is a perfect example of preparation meeting opportunity and that opportunity creating a great opportunity.”

In 2021, his Varsity Football debut year, Diphoko was crowned Player of the Tournament and received the Golden Boot award. A year later, he can barely believe it happened. “Yoh. It is huge! But it was all about the teamwork and support I got from my teammates.”

Changing students’ lives

A few South African teams wanted to sign him up, but his education was non-negotiable. A move abroad was eventually the best for Diphoko’s career – on and off the pitch.

Tenoff says the “talent identification pathway has now been paved”. The UFS understands the processes, what it is capable of, and it shows the university can equip and prepare students for international opportunities.

“It says that KovsieSport is serious about changing the lives of the students that come into our programme. It tells me that we have the will to make a way for our students. This is a small part of what is to come in KovsieSport, Kovsie Soccer, and the UFS.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept